Welcome to medications.com

Femcon FE News

Warner Chilcott Reports Operating Results for the Quarter and Year ... - MSN Money

We introduced and began commercial sales of FEMCON FE in the second half of 2006, but did not initiate promotional efforts in support of the product until ...

Posted: Fri Feb 29 07:08:35 -0500 2008

Warner Chilcott Announces 2008 Financial Guidance - HispanicBusiness.com (press release)

Total revenues for 2008 are expected to be in the range of $935 to $945 million, with the growth primarily being driven by LOESTRIN 24 FE, DORYX, FEMCON FE, ...

http://www.hispanicbusiness.com/n... | Posted: Tue Jan 29 17:26:56 -0500 2008

Warner Chilcott Announces 2008 Financial Guidance - CNNMoney.com

Total revenues for 2008 are expected to be in the range of $935 to $945 million, with the growth primarily being driven by LOESTRIN 24 FE, DORYX, FEMCON FE, ...

http://money.cnn.com/news/newsfee... | Posted: Mon Jan 28 07:37:41 -0500 2008

Warner Chilcott initiated with "sector perform" - newratings.com

... is poised to post impressive revenue growth of 18% for 2007, aided by the successful 2006 product launches of Taclonex, Loestrin 24-Fe and Femcon-Fe. ...

Posted: Tue Jan 15 10:28:57 -0500 2008

Warner Chilcott Limited Q3 2007 Earnings Call Transcript - Seeking Alpha

Before we began shipping Femcon, which we then called Ovcon Fe chewable a year ago. You should note that we did not initiate full promotional support for ...

Posted: Sun Nov 11 02:57:54 -0500 2007

Warner Chilcott Limited Q3 2007 Earnings Call Transcript - Seeking Alpha

Before we began shipping Femcon, which we then called Ovcon Fe chewable a year ago. You should note that we did not initiate full promotional support for ...

http://seekingalpha.com/article/5... | Posted: Sun Nov 11 02:57:54 -0500 2007

Warner Chilcott Reports Operating Results for the Quarter Ended ... - CNNMoney.com

We introduced and began commercial sales of FEMCON FE in the second half of 2006, but did not initiate promotional efforts in support of the product until ...

Posted: Fri Nov 09 07:07:30 -0500 2007

Warner Chilcott Reports Operating Results for the Quarter Ended ... - CNNMoney.com

We introduced and began commercial sales of FEMCON FE in the second half of 2006, but did not initiate promotional efforts in support of the product until ...

Posted: Fri Nov 09 07:07:30 -0500 2007

Warner Chilcott suing Watson over Femcon - Hemscott

The company claims that Watson subsidiary Watson Laboratories is infringing on the patent for the chewable oral contraceptive Femcon FE. ...

http://www.hemscott.com/news/late... | Posted: Mon Oct 01 07:13:20 -0400 2007

Warner Chilcott Files Lawsuit Against Watson Laboratories, Inc ... - PR Newswire (press release)

6667050 (the "050 Patent") which covers FEMCON FE, the first and only oral contraceptive that offers women the option of chewing their daily tablet. ...

http://sev.prnewswire.com/health-... | Posted: Mon Oct 01 21:24:07 -0400 2007




ADVERTISEMENT
© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com